A St. Louis jury awarded $70 million to a woman who used Johnson & Johnson baby powder and Shower to Shower products for decades and developed ovarian cancer. This is the third multi-million dollar verdict against Johnson & Johnson involving claims from women who used its talcum powder products for feminine hygiene and developed ovarian cancer. Two other juries awarded $72 million and $55 million to two women who claimed that Johnson & Johnson failed to warn them of an increased risk for developing ovarian cancer associated with talcum powder use.
Cohen & Malad, LLP attorneys have talked to hundreds of women who used Johnson & Johnson’s Shower to Shower and baby powder products for feminine hygiene for years and were diagnosed with ovarian cancer. If you or someone you know used the products and developed ovarian cancer, contact us for a free case evaluation.